Sunrest Lifescience Ltd
SUNRESTSunrest Lifescience Ltd
SUNRESTHealth CarePharmaceuticals
SmallcapWith a market cap of ₹25 cr, stock is ranked 3,902
High RiskStock is 4.26x as volatile as Nifty
62.003.33% (+2.00)
62.003.33% (+2.00)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 8.36 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.91 | 6.64 | 0.47% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Sunrest Lifescience is engaged in the marketing of over the counter (OTC) generic pharmaceutical products manufactured by third party manufacturers in the domestic market.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
48.19
1Y Return
70.03%
Buy Reco %
76.47
Cipla Ltd
PE Ratio
32.68
1Y Return
39.09%
Buy Reco %
69.70
Torrent Pharmaceuticals Ltd
PE Ratio
68.98
1Y Return
86.33%
Buy Reco %
75.86
Dr Reddy's Laboratories Ltd
PE Ratio
20.19
1Y Return
22.43%
Buy Reco %
35.71
Zydus Lifesciences Ltd
PE Ratio
28.17
1Y Return
75.22%
Buy Reco %
42.86
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Earnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Income
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 10.95 | 16.95 | 26.91 | 24.67 | 29.48 | — | ||||||
Raw Materials | 7.37 | 12.40 | 18.24 | 16.52 | 28.58 | — | ||||||
Power & Fuel Cost | 0.00 | 0.01 | 0.00 | 0.00 | ||||||||
Employee Cost | 2.06 | 2.37 | 2.54 | 2.92 | ||||||||
Selling & Administrative Expenses | 1.26 | 2.67 | 4.54 | 3.22 | ||||||||
Operating & Other expenses | 0.11 | -0.78 | 0.46 | -0.93 | ||||||||
EBITDA | 0.15 | 0.28 | 1.13 | 2.94 | 0.90 | — | ||||||
Depreciation/Amortization | 0.02 | 0.04 | 0.06 | 0.13 | 0.10 | — | ||||||
PBIT | 0.13 | 0.24 | 1.07 | 2.81 | 0.80 | — | ||||||
Interest & Other Items | 0.00 | 0.01 | 0.02 | 0.06 | 0.22 | — | ||||||
PBT | 0.13 | 0.23 | 1.05 | 2.75 | 0.58 | — | ||||||
Taxes & Other Items | 0.10 | 0.05 | 0.27 | 0.70 | 0.36 | — | ||||||
Net Income | 0.03 | 0.18 | 0.78 | 2.05 | 0.22 | — | ||||||
EPS | 0.10 | 0.60 | 2.60 | 6.83 | 0.68 | — | ||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticalsCompare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Sunrest Lifescience Ltd | 118.11 | 8.36 | — |
Sun Pharmaceutical Industries Ltd | 48.19 | 6.88 | 0.70% |
Cipla Ltd | 32.68 | 5.02 | 0.78% |
Torrent Pharmaceuticals Ltd | 68.98 | 16.66 | 0.83% |
Price Comparison
Compare SUNREST with any stock or ETFCompare SUNREST with any stock or ETF
SUNREST
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Nov 2023
Mar 2024
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SUNREST has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Articles & Videos
Sunrest Lifescience schedules AGM
Sunrest Lifescience announced that the 7th Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant